Amgen will continue to seek full approval for its Lumakras cancer drug as a treatment for a form of lung cancer.
You are here: Home / Top Stories / : Amgen to continue to seek full approval of Lumakras cancer drug after FDA panel criticizes trial
Market News and Views
Amgen will continue to seek full approval for its Lumakras cancer drug as a treatment for a form of lung cancer.